Dysregulation of sodium channel gating in critical illness myopathy

被引:0
|
作者
James W. Teener
Mark M. Rich
机构
[1] University of Michigan Health Systems,Department of Neurology
[2] Wright State University,Neuroscience, Cell Biology and Physiology (NCBP)
关键词
Action potential; Skeletal muscle; Weakness; Sepsis; Resting potential; Inactivation;
D O I
暂无
中图分类号
学科分类号
摘要
Critical illness myopathy (CIM) is the most common caused of acquired weakness in critically ill patients. While atrophy of muscle fibers causes weakness, the primary cause of acute weakness is loss of muscle excitability. Studies in an animal model of CIM suggest that both depolarization of the resting potential and a hyperpolarized shift in the voltage dependence of sodium channel gating combine to cause inexcitability. In active adult skeletal muscle the only sodium channel isoform expressed is Nav1.4. In the animal model of CIM the Nav1.5 sodium channel isoform is upregulated, but the majority of sodium current is still carried by Nav1.4 sodium channels. Experiments using toxins to selectively bock the Nav1.4 isoform demonstrated that the cause of the hyperpolarized shift in sodium channel inactivation is a hyperpolarized shift in inactivation of the Nav1.4 isoform. These data suggest that CIM represents a new type of ion channel disease in which altered gating of sodium channels is due to improper regulation of the channels rather than mutation of channels or changes in isoform expression. The hypothesis that dysregulation of sodium channel gating underlies inexcitability of skeletal muscle in CIM raises the possibility that there maybe dysregulation of sodium channel gating in other tissues in critically ill patients. We propose that there is a syndrome of reduced electrical excitability in critically ill patients that affects skeletal muscle, peripheral nerve, the heart and central nervous system. This syndrome manifests as CIM, critical illness polyneuropathy, reduced cardiac contractility and septic encephalopathy.
引用
收藏
页码:291 / 296
页数:5
相关论文
共 50 条
  • [31] A new twist to myopathy of critical illness
    Martyn, JAJ
    Vincent, A
    ANESTHESIOLOGY, 1999, 91 (02) : 337 - 339
  • [32] Critical illness myopathy associated with hyperthyroidism
    Pandey, HK
    Riggs, JE
    Schochet, SS
    MILITARY MEDICINE, 2004, 169 (01) : 71 - 72
  • [33] Critical illness weakness: Neuropathy or myopathy
    Smith, TA
    Fabricius, M
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2005, 10 : 89 - 89
  • [34] Approach to critical illness polyneuropathy and myopathy
    Pati, S.
    Goodfellow, J. A.
    Iyadurai, S.
    Hilton-Jones, D.
    POSTGRADUATE MEDICAL JOURNAL, 2008, 84 (993) : 354 - 360
  • [35] ACUTE NECROTIZING MYOPATHY OF CRITICAL ILLNESS
    RAMSAY, DA
    ZOCHODNE, DW
    LUDWIN, SK
    NAG, S
    ROBERTSON, DM
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1992, 51 (03): : 356 - 356
  • [36] Critical illness myopathy: what is happening?
    Friedrich, Oliver
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2006, 9 (04): : 403 - 409
  • [37] A new examination of critical illness myopathy
    Ng, Karl
    CLINICAL NEUROPHYSIOLOGY, 2021, 132 (06) : 1332 - 1333
  • [38] Critical illness myopathy: Deeper insights
    Young, G. Bryan
    CRITICAL CARE MEDICINE, 2008, 36 (06) : 1977 - 1977
  • [39] Critical illness myopathy: Glucocorticoids revisited?
    Z'Graggen, Werner J.
    Schefold, Joerg C.
    ACTA PHYSIOLOGICA, 2019, 225 (02)
  • [40] Management of Critical Illness Polyneuropathy and Myopathy
    Chawla, Jasvinder
    Gruener, Gregory
    NEUROLOGIC CLINICS, 2010, 28 (04) : 961 - +